Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of mesenchymal stem cells combined with PRP in preparation of medicine for treating vulva atrophy

A technology of vulva atrophy and mesenchymal stem cells, which is applied in the field of stem cells, can solve the problems of short duration of treatment effect and great pain, and achieve the effect of eliminating the risk of rejection, simple treatment, and eliminating sagging

Pending Publication Date: 2021-10-22
吴志新 +3
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, at present, most of the methods of repairing the atrophy of the labia and the size of the labia are filled with foreign bodies, and local subcutaneous artificial damage is repaired. The treatment effect lasts for a short time and causes great pain

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0018] Example 1: Application of autologous adipose-derived mesenchymal stem cells combined with PRP in the preparation of drugs for treating vulvar atrophy.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses application of mesenchymal stem cells combined with PRP (platelet-rich plasma) in preparation of a medicine for treating vulva atrophy. According to the invention, the autologous adipose-derived mesenchymal stem cells and the PRP are combined for treating the vulva atrophy, the autologous adipose-derived mesenchymal stem cells can be differentiated into adipose cells subcutaneously, the PRP can promote the improvement of capillary vessels, and the autologous adipose-derived mesenchymal stem cells and the PRP interact with each other, so that the atrophic vulva cells can be repaired and regenerated; the traditional Chinese medicine composition can effectively treat and improve symptoms of a patient remarkably. compared with an existing operation of repairing vulva atrophy, the traditional Chinese medicine composition is simpler in treatment and more simplified in operation steps, autologous cells and PRP are adopted, the rejection risk is eliminated, and the safety is higher.

Description

technical field [0001] The invention relates to the technical field of stem cells, in particular to the application of mesenchymal stem cells combined with PRP in the preparation of drugs for treating vulvar atrophy. Background technique [0002] Vulvar atrophy occurs in perimenopausal women and older women. Due to the overall extension of human life expectancy and the increasing demand for spiritual culture, private plastic surgery and cosmetology have become more and more popular items in medical and aesthetic services. However, at present, foreign body filling and repair of local subcutaneous artificial damage are mostly used in repairing the atrophy of labia and labia. The maintenance time of the treatment effect is short and the pain is great. [0003] Mesenchymal stem cells are an important member of the stem cell family, derived from the mesoderm in the early stage of development, belonging to pluripotent stem cells, and exist in various tissues (such as bone marrow,...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K35/28A61K9/00A61P15/02A61P17/00A61K35/19A61K35/16
CPCA61K35/28A61K35/19A61K35/16A61K9/0034A61K9/0019A61P15/02A61P17/00A61K2300/00
Inventor 吴志新李飚李沛沛孙靖
Owner 吴志新
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com